SCHEMBL7661111

SCHEMBL7661111

O=C1COC(C#Cc2ccccc2)(C(F)(F)F)c2cc(Cl)ccc2N1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 10/20 0.48
CYP46A1 Q9Y6A2 6/20 0.48
MAPT P10636 3/20 0.48
NR1I2 O75469 1/20 0.48
NR3C1 P04150 1/20 0.48
ADRB1 P08588 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CNR1 P21554 1/20 0.48
SLC6A2 P23975 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
MAPK1 P28482 1/20 0.48
AGTR1 P30556 1/20 0.48
CCKBR P32239 1/20 0.48
PPARG P37231 1/20 0.48
OPRK1 P41145 1/20 0.48
SLC6A3 Q01959 1/20 0.48
PDE4D Q08499 1/20 0.48
PDE3A Q14432 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7659985 0.88 CYP46A1 (0.45) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL1151823 0.83 CYP46A1 (0.65) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL1152605 0.81 PGR (0.72) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL1152462 0.81 CYP46A1 (0.59) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL1152420 0.81 PGR (0.49) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL1152913 0.81 PGR (0.49) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL1152662 0.78 PGR (0.55) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL10709026 0.73 PGR (0.71) PGRMAPTCNR1OPRK1PDE4D
SCHEMBL7954675 0.70 CYP46A1 (0.62) PGRCYP46A1MAPTNR1I2NR3C1
SCHEMBL10707384 0.69 PGR (0.56) PGRAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6489320-B1 NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND BENZOXAPINONE FOR TREATMENT OF HIV INFECTION BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-12-03 US claimed
US-6489320-B1 NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR AND BENZOXAPINONE FOR TREATMENT OF HIV INFECTION BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-12-03 US disclosed
US-6140320-A FOR TREATING HIV(HUMAN IMMUNODEFICIENCY VIRUS) INFECTIONS DUPONT PHARMACEUTICALS COMPANY (US) 2000-10-31 US disclosed